Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

5,995 public trials 1,209 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Active, Not Recruiting

Study of Olaparib and Durvalumab in IDH-Mutated Solid Tumors

NCT03991832

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +10 more
Locations: Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details

Active, Not Recruiting

Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer

NCT03110978

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +32 more
Locations: MD Anderson in The Woodlands Conroe, Texas, United States

M D Anderson Cancer Center Houston, Texas, United States

MD Anderson West Houston Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma

NCT05524935

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +12 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Active, Not Recruiting

LIQUID BIOPSY IN Low-grade Glioma Patients

NCT05133154

Conditions: Glioma, Neoplasm Metastasis, Neoplasms, +10 more
Locations: University Hospital, Montpellier Montpellier, France

View Trial Details

Active, Not Recruiting

Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer

NCT06416085

Conditions: Advanced Cancer, Endocrine Cancer, Endocrine Gland Neoplasms, +28 more
Locations: Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details

Active, Not Recruiting

Combination or Sequence of Vemurafenib, Cobimetinib, and Atezolizumab in High-risk, Resectable Melanoma

NCT04722575

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Ospedale S.M. Annunziata - Azienda USL Toscana Centro Bagno a Ripoli, Firenze, Italy

IRCCS - Istituto Scientifico Romagnolo per la Cura e lo Studio dei Tumori (I.R.S.T) S.r.l. Meldola, Forlì-Cesena, Italy

Fondazione I.R.C.C.S. Istituto Nazionale dei Tumori Milan, Milano, Italy

Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione Giovanni Pascale" Naples, Italy

View Trial Details

Active, Not Recruiting

In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors

NCT04616248

Conditions: Adenocarcinoma, Anatomic Stage IV Breast Cancer AJCC v8, Basal Cell Carcinoma, +44 more
Locations: Los Angeles General Medical Center Los Angeles, California, United States

USC/Norris Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Active, Not Recruiting

PEP-CMV in Recurrent MEdulloblastoma/Malignant Glioma

NCT03299309

Conditions: Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +17 more
Locations: Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Active, Not Recruiting

18F-Fluorodopamine PET Studies of Neuroblastoma and Pheochromocytoma

NCT03541720

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +10 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Active, Not Recruiting

Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)

NCT03213704

Conditions: Advanced Malignant Solid Neoplasm, Central Nervous System Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +83 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

Providence Alaska Medical Center Anchorage, Alaska, United States

Banner Children's at Desert Mesa, Arizona, United States

Banner University Medical Center - Tucson Tucson, Arizona, United States

View all 124 locations

View Trial Details

Neuroectodermal Tumors

Neuroectodermal Tumors trial results

Related conditions